NXD07

N/A

Report date: 2023/11/06 09:57:19
NME

Base Information

Drug NameNXD07
Drug Alias NameNXD07NXD-07
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK degraders
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsWaldenstrom MacroglobulinemiaLeukemia, Mast-CellLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Neox Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Neox Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsWaldenstrom MacroglobulinemiaLeukemia, Mast-CellLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A